divendres, 3 d’octubre del 2014

Medtronic is still in on Covidien buyout




Medtronic says it will still pursue the acquisition of Covidien, using $16 billion in "external financing" to back the deal instead of the foreign cash it planned to use.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZAxBVA

Cap comentari:

Publica un comentari a l'entrada